From: Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli
Target
Name of primer
Sequence (5′ ➔ 3′)
Expected size of amplicon (bp)
Reference
CTX-M-1 group
CTX-M-1F
CTX-M-1R
GCAGCACCAGTAAAGTGATGGGCTGGGTGAAGTAAGTGACC
591
[28]
CTX-M-9 group
CTX-M-9F
CTX-M-9R
GCTGGAGAAAAGCAGCGGAGGTAAGCTGACGCAACGTCTG
474
[29]